BSE Live
Jan 22, 16:01Prev. Close
4040.90
Open Price
4087.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 22, 15:55Prev. Close
4041.90
Open Price
4050.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Sanofi India (in Rs. Cr.) | Dec 19 | Dec 18 | Dec 17 | Dec 16 | Dec 15 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 23.00 | 23.00 | 23.00 | 23.00 | 23.03 | |
| Total Share Capital | 23.00 | 23.00 | 23.00 | 23.00 | 23.03 | |
| Reserves and Surplus | 2,419.30 | 2,196.20 | 2,003.40 | 1,712.30 | 1,603.87 | |
| Total Reserves and Surplus | 2,419.30 | 2,196.20 | 2,003.40 | 1,712.60 | 1,604.13 | |
| Total Shareholders Funds | 2,442.30 | 2,219.20 | 2,026.40 | 1,735.60 | 1,627.16 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 44.60 | 92.10 | 103.10 | 96.60 | 120.28 | |
| Other Long Term Liabilities | 54.10 | 49.10 | 46.50 | 11.90 | 11.41 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 28.10 | 28.81 | |
| Total Non-Current Liabilities | 98.70 | 141.20 | 149.60 | 136.60 | 160.50 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade Payables | 368.90 | 343.80 | 326.90 | 242.40 | 225.61 | |
| Other Current Liabilities | 196.30 | 151.30 | 149.90 | 111.00 | 106.10 | |
| Short Term Provisions | 138.20 | 128.40 | 124.90 | 314.40 | 285.24 | |
| Total Current Liabilities | 703.40 | 623.50 | 601.70 | 667.80 | 616.95 | |
| Total Capital And Liabilities | 3,244.40 | 2,983.90 | 2,777.70 | 2,540.00 | 2,404.61 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 352.70 | 547.90 | 546.10 | 561.10 | 557.53 | |
| Intangible Assets | 146.00 | 184.90 | 222.90 | 248.70 | 319.60 | |
| Capital Work-In-Progress | 12.70 | 16.40 | 24.40 | 29.40 | 17.78 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 516.10 | 753.90 | 799.10 | 843.40 | 899.19 | |
| Non-Current Investments | 0.00 | 0.20 | 0.20 | 0.20 | 0.24 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 460.20 | 512.90 | 418.10 | 128.60 | 259.84 | |
| Other Non-Current Assets | 138.80 | 124.70 | 116.50 | 0.50 | 1.66 | |
| Total Non-Current Assets | 1,115.10 | 1,391.70 | 1,333.90 | 972.70 | 1,160.93 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 469.60 | 483.10 | 415.60 | 493.10 | 479.22 | |
| Trade Receivables | 224.00 | 158.40 | 195.10 | 144.80 | 144.06 | |
| Cash And Cash Equivalents | 1,129.50 | 831.90 | 729.90 | 558.50 | 571.51 | |
| Short Term Loans And Advances | 1.50 | 4.30 | 3.50 | 362.70 | 43.73 | |
| OtherCurrentAssets | 304.70 | 114.50 | 99.70 | 8.20 | 5.16 | |
| Total Current Assets | 2,129.30 | 1,592.20 | 1,443.80 | 1,567.30 | 1,243.68 | |
| Total Assets | 3,244.40 | 2,983.90 | 2,777.70 | 2,540.00 | 2,404.61 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 290.60 | 235.80 | 203.30 | 170.70 | 120.99 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 261.00 | 284.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 375.50 | 271.58 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 375.50 | 271.58 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 25.10 | 15.98 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 831.80 | 758.70 | 525.70 | 21.90 | 13.01 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | 25.00 | 25.04 | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 870.70 | 714.50 | 630.60 | 580.10 | 531.15 | |
| Other Earnings | -- | -- | -- | 134.40 | 136.87 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 18.38 | 18.38 | 18.38 | 18.38 | 18.38 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | 0.20 | 0.20 | 0.20 | 0.24 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
01.08.2025
16.07.2025
Emcure Pharma announces deal with Sanofi India to distribute oral anti-diabetic products in India
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
03.11.2025
Sanofi India Standalone September 2025 Net Sales at Rs 475.40 crore, down 9.27% Y-o-Y
15.05.2025
Sanofi India Standalone March 2025 Net Sales at Rs 535.90 crore, down 26.83% Y-o-Y
17.03.2025
Sanofi India Consolidated December 2024 Net Sales at Rs 514.90 crore, down 25.8% Y-o-Y
29.07.2024
Sanofi India Consolidated June 2024 Net Sales at Rs 463.50 crore, down 34.36% Y-o-Y